Q-omics provides the consensus-scored UBE2V1P9 profile across patient tissues and cancer cell-line models. UBE2V1P9 expression is associated with patient survival in 10 of 34 cancer types, with the highest sampling consensus in PAAD. Additionally, UBE2V1P9 RNA expression shows 5,780 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight PAAD, and STAD as cancer lineages where UBE2V1P9 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for UBE2V1P9 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes UBE2V1P9 survival associations across molecular data types. UBE2V1P9 RNA expression shows survival associations in the most cancer types (10). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

UBE2V1P9 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	10	PAAD (45)	view →

This table ranks reproducible UBE2V1P9 RNA expression–survival associations across cancer types. High UBE2V1P9 expression shows unfavorable associations in PAAD, LUSC, KICH, CHOL, DLBC and STAD. The PAAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .002). Together, the overview and detailed table identify PAAD as the clearest survival context for UBE2V1P9 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	OS	Tertile	II,III,IV	0.205	0.556	.002	45	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	42	view →
KICH	DFS	Tertile	All	0.102	0.848	.004	39	view →
CHOL	DFS	Tertile	All	0.045	0.499	<.001	36	view →
DLBC	OS	Tertile	II,III,IV	0.115	0.839	<.001	36	view →
STAD	OS	Quartile	II,III,IV	0.341	0.604	.030	12	view →

Pink = unfavorable, green = favorable. all 10 lineages →

UBE2V1P9-PAAD (OS)

Kaplan–Meier survival curve for UBE2V1P9 RNA expression in PAAD: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with UBE2V1P9 in patient tissues and cancer cell lines. In patient samples, UBE2V1P9 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	5,780	STAD (5374)	view →
RNA	2,293	LUAD (882)	view →